Abstract:Nano‐metformin, encapsulated within pectin nanoparticles, enhances the efficacy of metformin against colorectal cancer (CRC) cells. It exhibits significant dose‐dependent cytotoxicity, anti‐inflammatory effects, and induces apoptotic cell death by regulating key apoptotic markers. Nano‐metformin also causes DNA damage and reduces cell migration, presenting a promising therapeutic strategy for CRC treatment. Colorectal cancer (CRC) continues to be a significant health challenge, necessitating the development of efficient therapeutic strategies. Drug repurposing, which involves the use of existing medications for new purposes, presents a promising opportunity. Metformin, a widely used antidiabetic drug, has demonstrated potential anticancer effects. To enhance its efficacy, we formulated nano‐metformin, metformin encapsulated within pectin nanoparticles. Our study aimed to evaluate the superiority of nano‐metformin over free metformin in treating CRC. The cytotoxicity of both metformin and nano‐metformin on Caco‐2 CRC cells was assessed using the MTT assay, revealing a significant dose‐dependent inhibition of cell growth using nano‐metformin. The anti‐inflammatory potential was evaluated by measuring the levels of nitric oxide and the pro‐inflammatory cytokines IL‐2 and IL‐6 following lipopolysaccharide (LPS) induction, and the results revealed that treating LPS‐induced cells with nano‐metformin significantly reduced the production of these inflammatory mediators. To elucidate the mechanism of cell death, we employed an acridine orange/ethidium bromide staining assay, which revealed the enhancement of apoptotic cell death following treatment with nano‐metformin. Additionally, we examined the expression of key apoptotic regulators using real‐time qPCR. Nano‐metformin, in particular, significantly downregulated the expression of the antiapoptotic markers Bcl‐2 and Survivin while upregulating the proapoptotic caspases 3, 7, and 9. The comet assay revealed significant DNA damage induced by treatment with the nano‐metformin compared with that in the free form. Moreover, nano‐metformin significantly reduced the migration ability of cells. In conclusion, our work revealed the superior efficacy of our formulated nanoform over free metformin, highlighting its potential as a promising therapeutic agent for CRC treatment.

Autophagic blockage by metformin-loaded PLGA nanoparticles causes cell cycle arrest of HepG2 cells

Metformin-Induced Stromal Depletion to Enhance the Penetration of Gemcitabine-Loaded Magnetic Nanoparticles for Pancreatic Cancer Targeted Therapy

Sugar-Coated Nanobullet: Growth Inhibition of Cancer Cells Induced by Metformin-Loaded Glyconanoparticles.

Metformin Induces Autophagy via the AMPK-mTOR Signaling Pathway in Human Hepatocellular Carcinoma Cells

Dual Blockade of Lactate/GPR81 and PD-1/PD-L1 Pathways Enhances the Anti-Tumor Effects of Metformin

Effects of metformin on cancers in experimental and clinical studies: Focusing on autophagy and AMPK/mTOR signaling pathways

Metformin induces autophagy and G0/G1 phase cell cycle arrest in myeloma by targeting the AMPK/mTORC1 and mTORC2 pathways

The Effect of Autophagy Inhibitors on Drug Delivery Using Biodegradable Polymer Nanoparticles in Cancer Treatment.

Basal Autophagy and Feedback Activation of Akt Are Associated with Resistance to Metformin-Induced Inhibition of Hepatic Tumor Cell Growth

Characterization and evaluation of metformin-loaded solid lipid nanoparticles for celluar and mitochondrial uptake.

Preventative and Therapeutic Effects of Metformin in Gastric Cancer: A New Contribution of an Old Friend

Proteomic Analysis Reveals That Metformin Suppresses PSMD2, STIP1, and CAP1 for Preventing Gastric Cancer AGS Cell Proliferation and Migration

Inhibition of Autophagy Promotes the Anti-Tumor Effect of Metformin in Oral Squamous Cell Carcinoma

Functionalized Selenium Nanoparticles Synergizes With Metformin to Treat Breast Cancer Cells Through Regulation of Selenoproteins

Metformin Attenuates Hepatoma Cell Proliferation by Decreasing Glycolytic Flux Through the HIF-1α/PFKFB3/PFK1 Pathway.

Enhanced anticancer effect of lysozyme-functionalized metformin-loaded shellac nanoparticles on a 3D cell model: role of the nanoparticle and payload concentrations

Enhancing the anticancer effect of metformin through nanoencapsulation: Apoptotic induction, inflammatory reduction, and suppression of cell migration in colorectal cancer cells

Mechanisms of cancer cell killing by metformin: a review on different cell death pathways

Metformin induces cell cycle arrest, apoptosis and autophagy through ROS/JNK signaling pathway in human osteosarcoma

Metformin triggers the intrinsic apoptotic response in human AGS gastric adenocarcinoma cells by activating AMPK and suppressing mTOR/AKT signaling

The anticancer effect of metformin targets VDAC1 via ER-mitochondria interactions-mediated autophagy in HCC